TerrAscend (TSNDF) Net Cash Flow (2021 - 2026)
TerrAscend (TSNDF) reported Net Cash Flow of $164000.0 for Q1 2026, down 97.05% year-over-year from $5.6 million in Q1 2025, and down 98.27% quarter-over-quarter from $9.5 million in Q4 2025.
TerrAscend (TSNDF) Net Cash Flow (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Net Cash Flow data on file, last reported at $164000.0 in Q1 2026.
- Net Cash Flow for Q1 2026 came in at $164000.0, down 97.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.0 million (down 0.66% YoY), and the FY2025 annual result was $20.4 million, up 108.71% from the prior year.
- Net Cash Flow fell to $164000.0 in Q1 2026 per TSNDF's latest filing, from $9.5 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $14.6 million in Q1 2022 and troughed at -$40.8 million in Q2 2022.
- A 5-year average of -$453941.2 and a median of $229000.0 in 2024 frame the typical range for Net Cash Flow.
- On a YoY basis, Net Cash Flow climbed as much as 2327.51% in 2025 and fell as far as 223.16% in 2025.
- A 5-year view of Net Cash Flow shows it stood at -$9.7 million in 2022, then jumped by 65.57% to -$3.3 million in 2023, then soared by 336.49% to $7.9 million in 2024, then advanced by 20.05% to $9.5 million in 2025, then tumbled by 98.27% to $164000.0 in 2026.
- Business Quant data shows TSNDF's Net Cash Flow at $164000.0 in Q1 2026, $9.5 million in Q4 2025, and $10.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 202.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -526.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -277.40 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -446.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -112.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -768.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -3.97 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 139.49 Mn |
| 10 | TerrAscend | - | - | 34.60 Mn | 164,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 164,000.00 |
| Mar 31, 2026 | 164,000.00 |
| Dec 31, 2025 | 9.47 Mn |
| Dec 31, 2025 | 9.47 Mn |
| Sep 30, 2025 | 10.95 Mn |
| Sep 30, 2025 | 10.95 Mn |
| Jun 30, 2025 | -5.57 Mn |
| Jun 30, 2025 | -5.57 Mn |
| Mar 31, 2025 | 5.56 Mn |
| Mar 31, 2025 | 5.56 Mn |
| Dec 31, 2024 | 7.89 Mn |
| Dec 31, 2024 | 7.89 Mn |
| Sep 30, 2024 | -2.87 Mn |
| Sep 30, 2024 | -2.87 Mn |
| Jun 30, 2024 | 4.53 Mn |
| Jun 30, 2024 | 4.53 Mn |
| Mar 31, 2024 | 229,000.00 |
| Mar 31, 2024 | 229,000.00 |
| Dec 31, 2023 | -3.34 Mn |
| Dec 31, 2023 | -3.34 Mn |